AbbVie

YTD

ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Robert A. Michael

CEORobert A. Michael

Employees

55,000

Employees55,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

55,000

Employees55,000

ABBV Key Statistics

Market cap

328.61B

Market cap328.61B

Price-Earnings ratio

79.09

Price-Earnings ratio79.09

Dividend yield

3.44%

Dividend yield3.44%

Average volume

4.48M

Average volume4.48M

High today

$187.12

High today$187.12

Low today

$183.70

Low today$183.70

Open price

$185.58

Open price$185.58

Volume

2.21M

Volume2.21M

52 Week high

$218.66

52 Week high$218.66

52 Week low

$163.52

52 Week low$163.52

ABBV News

Simply Wall St 1h

AbbVie Announces Positive Phase 3 Results for Migraine Drug Atogepant

recently announced positive results from its Phase 3 TEMPLE study, marking significant progress in migraine treatment. Over the last month, AbbVie’s stock price...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

40%

Sell

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.